Dr Reddy's eyes 20 per cent growth in domestic sales in FY16

Dr Reddy's Laboratories, the country's second-largest drugmaker by sales, expects its domestic sales to grow nearly 20 per cent in the financial year ending March 2016, helped by the launch of nearly two dozen new drugs, said a senior executive.

The domestic market is the second-biggest market after the United States and contributed 15 per cent to its total sales last year.

"In the last year we launched close to 25 brands in India, and, directionally, you can expect that trend to continue this year," Dr Reddy's India business head Alok Sonig told Reuters in an interview.

(Reuters)